Try our Advanced Search for more refined results
February 28, 2013
Depomed Inc. v. Watson Laboratories Inc. - Florida et al
Case Number:
1:13-cv-00342
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
March 01, 2013
Depomed Targets Generics Maker Over Diabetes Drug IP
Pharmaceutical company Depomed Inc. filed a patent infringement suit Thursday in Delaware federal court against Watson Laboratories Inc., saying the company's planned generic version of Depomed's extended-release metformin drug Glumetza for Type II diabetes violates four patents.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login